Loading...
XCSE
PEG
Market cap19mUSD
Dec 05, Last price  
0.10DKK
1D
0.49%
1Q
-28.97%
IPO
-74.88%
Name

Pharma Equity Group A/S

Chart & Performance

D1W1MN
XCSE:PEG chart
P/E
—
P/S
—
EPS
—
Div Yield, %
—
Shrs. gr., 5y
39.29%
Rev. gr., 5y
%
Revenues
0k
00517,00015,486,00013,252,00000620,0001,054,00000000000
Net income
-24m
L-0.76%
-92,669,000-12,036,000-1,415,000-16,978,000-43,279,000-141,827,000-5,930,000-2,773,000-1,035,000177,000-7,713,000-14,417,000-32,875,0005,392,0003,479,000-24,609,000-24,422,000
CFO
-23m
L+37.52%
0-744,000-17,747,000-5,713,000-10,559,000-5,789,000-4,800,000-2,938,000-181,000-4,921,000-1,579,000-274,000-9,905,000-2,089,000-2,874,000-16,624,000-22,861,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Pharma Equity Group A/S invests in companies with a primary focus on life sciences. It focuses on early investment in life science companies that develop technologies and therapies that enhances human health and quality of life. The company is based in Hørsholm, Denmark.
URL
https://pharmaequitygroup.com/
IPO date
Jun 25, 2003
Employees
Domiciled in
DK
Incorporated in
DK

Valuation

Title
DKK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT